Ozempic And Wegovy Can Lead To Major Muscle Loss – This Company May Have A Solution

Dr. Jordan R. Plews, PhD, Co-Founder & CEO of Elevai Labs, Inc ELAB, was recently a guest on Benzinga's All Access.

Elevai is a medical aesthetic biotechnology company that develops innovative skincare products and treatments tied to obesity and metabolic health. The company's biotech division is currently developing EL-22, designed to help users of drugs like Ozempic keep lean muscle mass as they lose weight.

The company recently released preclinical data showing promising results for EL-22.

Watch the full interview here:

Featured photo by i yunmai on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.